AI brief of an SEC Form 8-K · Visteon (VC)

Visteon Q4 sales fall to $939 million and net income drops to $122 million

Mixed Impact 3 of 5 earnings Written later

Visteon reported fourth-quarter and full-year 2024 results in which net sales and GAAP net income declined from 2023, while adjusted EBITDA reached a record for the full year. The company also issued 2025 guidance for sales, adjusted EBITDA and adjusted free cash flow, and the compensation committee approved officer pay increases effective April 1, 2025.

Key points

  • Q4 2024 net sales were $939 million versus $990 million a year earlier, and diluted EPS was $4.37 versus $12.98.
  • Full-year 2024 net sales were $3,866 million versus $3,954 million, and net income was $274 million versus $486 million, with diluted EPS of $9.82 versus $17.05.
  • Full-year 2024 adjusted EBITDA was a record $474 million versus $434 million in 2023. 2025 guidance is sales of $3.65 billion to $3.85 billion and adjusted EBITDA of $450 million to $480 million, excluding any 2025 tariff impact.
  • On February 16, 2025, the committee approved pay increases for certain officers, including a $1,150,000 base salary and $10,000,000 long-term incentive award for CEO Sachin Lawande.

The filing

CompanyVisteon (VC)
Form8-K, current report
Filed with the SECFeb 18, 2025, 7:02 AM ET
Accession number0001111335-25-000005

Items reported: 2.02 Results of Operations5.02 Director / Officer Change7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:55 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 18, 2025.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.